Hello Tek community,

We’re pleasing to share an exciting and cutting-edge development today from Tekcapital portfolio company Belluscura. The primary cause of death from Coronavirus is respiratory failure, and this new technology provides supplemental oxygen to the patient in a way that bypasses the lungs. Read more on UK Investor Magazine.

This is a key example of how rapid innovation can help solve some of the world’s most destructive problems. Tek aims to be a thought leader in the global innovation space, by getting access to extraordinarily important technologies such as to the general public.